Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 1/20 | 0.41 |
| ▸ | CTSK | P43235 | 1/20 | 0.41 |
| ▸ | KIF11 | P52732 | 3/20 | 0.41 |
| ▸ | AR | P10275 | 10/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | MPL | P40238 | 3/20 | 0.38 |
| ▸ | KMO | O15229 | 2/20 | 0.37 |
| ▸ | PGR | P06401 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12117710 | 0.97 | CTSS (0.40) | CTSSCTSKKIF11ARALDH1A1 | |
| SCHEMBL12198575 | 0.97 | CTSS (0.40) | CTSSCTSKKIF11ARALDH1A1 | |
| SCHEMBL14233920 | 0.92 | AR (0.40) | CTSSCTSKKIF11ARALDH1A1 | |
| SCHEMBL12149119 | 0.90 | CTSS (0.38) | CTSSCTSKKIF11ARALDH1A1 | |
| SCHEMBL12117707 | 0.90 | CTSS (0.38) | CTSSCTSKKIF11ARALDH1A1 | |
| SCHEMBL10075599 | 0.88 | KIF11 (0.55) | KIF11ALDH1A1GAAMAPTPKM | |
| SCHEMBL16433730 | 0.87 | KIF11 (0.35) | CTSSCTSKKIF11ARALDH1A1 | |
| SCHEMBL12149156 | 0.87 | FFAR4 (0.37) | CTSSCTSKKIF11ARALDH1A1 | |
| SCHEMBL19799328 | 0.87 | CTSS (0.39) | CTSSCTSKKIF11ARALDH1A1 | |
| SCHEMBL30019760 | 0.87 | MPL (0.44) | CTSSCTSKKIF11ARMPL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8119828-B2 | Material for an organic electroluminescence device and an organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2012-02-21 | — | — | US | disclosed |
| US-20100044686-A1 | MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100044686-A1 | MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE | AFF4, KCNH3, HCN4 | CTSS 2103/4885CTSK 3610/4885KIF11 2450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.